Either you have JavaScript disabled or your browser does not support Javascript . To work properly, this page requires JavaScript to be enabled.
How to enable JavaScript in your browser?

Zurletrectinib - InnoCare Pharma

Next Previous
Drug Profile

Zurletrectinib - InnoCare Pharma

Alternative Names: ICP 723

Latest Information Update: 11 Jun 2025

Price :
$50 *
Note:
  • Adis is an information provider. We do not sell or distribute actual drugs.
  • Final gross price and currency may vary according to local VAT and billing address.
  • Your purchase entitles you to full access to the information contained in our drug profile at the time of purchase.
  • A link to download a PDF version of the drug profile will be included in your email receipt.

At a glance

  • Originator InnoCare Pharma
  • Class Antineoplastics; Aza compounds; Fluorinated hydrocarbons; Fluorocarbons; Ketones; Pyrazoles; Pyridines; Pyrrolidines; Small molecules
  • Mechanism of Action Tropomyosin-related kinase antagonists
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.

    No
  • New Molecular Entity Yes

Highest Development Phases

  • Preregistration Solid tumours

Most Recent Events

  • 02 Jun 2025 Updated efficacy data from a phase I/II trial in Solid tumours released by InnoCare Pharma
  • 28 May 2025 No recent reports of development identified for phase-I development in Solid-tumours(Late-stage disease, Metastatic disease, Second-line therapy or greater) in USA (PO, Tablet)
  • 02 May 2025 zurletrectinib received priority review by the Center for Drug Evaluation (CDE) of the China National Medical Products Administration (NMPA)

You need to be a logged in or subscribed to view this content

Request demo (opens in a new window)
If your organization or you do not have a subscription, try one of the following: If your organization has a subscription, there are several access options, even while working remotely:
  • Working within your organization’s network
  • with username/password or try to via your institution
  • Persisted access using your organization’s identifier stored in your user browser for 90 days
Back to top